Vertex Pharmaceuticals Inc. buy Barclays PLC
Start price
27.01.26
/
50%
€396.70
Target price
27.01.27
-
Performance (%)
14.83%
Price
19:58
€455.55
Summary
This prediction is currently active. The prediction currently has a performance of 14.83%. This prediction currently runs until 27.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 10.633% | 10.633% |
| iShares Core DAX® | 0,18 % | 5,07 % |
| iShares Nasdaq 100 | -0,77 % | -2,08 % |
| iShares Nikkei 225® | 0,73 % | -3,35 % |
| iShares S&P 500 | -0,17 % | 0,90 % |
Comments by Barclays_PLC for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Barclays_PLC for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€387.70
06.02.24
06.02.24
€439.24
06.02.25
06.02.25
19.98%
07.02.25
07.02.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.60
11.12.23
11.12.23
€385.41
11.12.24
11.12.24
35.84%
12.12.24
12.12.24